Wockhardt532300Quarterly results
Board approves unaudited Q2 and H1 results; auditors give clean limited-review conclusion
Wockhardt's board met on 2nd November, 2026 (12:05 p.m. to 3:45 p.m.) and approved the Un-Audited Financial Results (Standalone & Consolidated) for the quarter and half year ended 30th September, 2026.
By ScoutQuest · · 3 min read
100 (Rs in Crore)+85.2%
202554 (Rs in Crore)2026100 (Rs in Crore)
- Standalone Revenue from Operations (Q2 FY27)
- Rs. 580 crore vs Rs. 380 crore in Q2 FY26
- Standalone Net Profit after tax (Q2)
- Rs. 100 crore vs Rs. 54 crore
- Auditor Conclusion
- Clean limited-review conclusion on standalone and consolidated results
What the board approved
- The Board of Directors met on 2nd November, 2026, from 12:05 p.m. to 3:45 p.m., and approved the Un-Audited Financial Results (Standalone & Consolidated) for the quarter and half year ended 30th September, 2026.
- The results were reviewed by the Audit Committee and approved by the Board, and were subjected to a limited review by MSKC & Associates LLP, the statutory auditors.
- The company states it is exclusively into the Pharmaceutical business segment.
Auditor's conclusion
- The standalone and consolidated review reports both carry a clean conclusion: based on the review, nothing came to the auditors' attention that causes them to believe the statements contain any material misstatement.
- A review is narrower than a full audit. It relies mainly on inquiries and analytical procedures, and the auditors do not express an audit opinion.
Standalone results (Rs in Crore)
- Revenue from operations: 580 for the quarter ended 30/09/2026, against 380 for the quarter ended 30/09/2025; 1,141 for the six months, against 793.
- Total income: 601 for the quarter, against 410; 1,195 for the six months, against 848.
- Total expenses: 501 for the quarter, against 356; 988 for the six months, against 725.
- Profit before tax: 100 for the quarter, against 54; 207 for the six months, against 123.
- Net Profit after tax: 100 for the quarter, against 54; 207 for the six months, against 123.
- Basic earnings per share: 6.15 for the quarter, against 3.26; 12.77 for the six months, against 7.51 (face value of Rs. 5/- each, not annualised). Diluted: 6.14 and 12.75.
Balance sheet, standalone (Rs in Crore)
- Total assets: 6,180 as at 30/09/2026, against 5,935 as at 31/03/2026.
- Total equity: 3,293, against 3,084.
- Total liabilities: 2,887, against 2,851.
- Non-current borrowings: 1,177, against 1,244; current borrowings: 627, against 501.
Cash flow, standalone (Rs in Crore)
- Net cash inflow from operating activities: 242 for the six months ended 30/09/2026, against 77 for the six months ended 30/09/2025.
- Net cash outflow from investing activities: 113, against 379.
- Net cash outflow from financing activities: 57, against an inflow of 326.
- Cash and cash equivalents at the end of the period: 148, against 59.
Group scope covered by the consolidated review
- The consolidated statement includes the holding company and 28 subsidiaries listed in the review report, including Wockhardt UK Holdings Limited (wholly owned), CP Pharmaceuticals Limited, Wallis Group Limited and The Wallis Laboratory Limited (step-down subsidiaries).
- For 5 subsidiaries whose interim financial information the auditors did not review, that information reflects total assets of Rs. 6923 crores, total revenues of Rs. 836 crores and Rs.1612 crores, total net profit after tax of Rs.30 crores and Rs. 28 crores, and cash flows (net) of Rs. (6) crores for the period from April 01, 2026 to September 30, 2026.
- For 18 subsidiaries whose interim financial information was not reviewed by their auditors, it reflects total assets of Rs. 489 crores, total revenue of Rs. 44 crores and Rs. 90 crores, total net profit after tax of Rs. 4 crores and Rs. 14 crores, and cash flows (net) of Rs. 18 crores for the same period.
- The auditors state their conclusion is not modified in respect of these matters.
What a retail reader can take away
- The update is a routine quarterly result announcement, but it carries the numbers that matter: the standalone revenue, profit and cash-flow lines all show higher figures for the quarter and half year compared with the corresponding periods a year earlier.
- The auditor sign-off is a limited review, not a full audit — the interim nature of these numbers is worth keeping in mind when comparing them with annual audited figures.
- The consolidated picture includes several subsidiaries whose numbers were reviewed by other auditors or prepared by management; the review report quantifies the size of those blocks so a reader can weigh how much of the group they represent.
Also from Wockhardt
CRISIL monitoring report: no deviation in QIP proceeds utilisation
2 Nov 2026
Sumit Garg identified and designated as Senior Management Personnel; continues as Chief Digital & Information Officer
2 Nov 2026
Dealing room checks show buy flows and higher delivery volumes on Wockhardt
2 Nov 2026
More numbers
- Revenue from operations, quarter ended 30/09/2026 (standalone)580 (Rs in Crore)
- Revenue from operations, quarter ended 30/09/2025 (standalone)380 (Rs in Crore)
- Net Profit after tax, quarter ended 30/09/2026 (standalone)100 (Rs in Crore)
- Net Profit after tax, quarter ended 30/09/2025 (standalone)54 (Rs in Crore)
- Total income, six months ended 30/09/2026 (standalone)1,195 (Rs in Crore)
- Net cash inflow from operating activities, six months ended 30/09/2026242 (Rs in Crore)
- Total assets as at 30/09/2026 (standalone)6,180 (Rs in Crore)
- Total assets of 18 subsidiaries not reviewed by their auditorsRs. 489 crores
Source: BSE · 2 Nov 2026
Nothing here is a view, opinion or recommendation of ScoutQuest, its parent, directors or employees. ScoutQuest is a technology company: this page was assembled automatically from public sources using artificial intelligence, and may contain errors or omissions. Confirm everything against the original source before you act on it. Any use of this page is at your own risk, and neither ScoutQuest nor its parent, directors or employees accepts liability for it.